SNG — Synairgen Cashflow Statement
0.000.00%
Last trade - 00:00- £10.48m
- £1.88m
Annual cashflow statement for Synairgen, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.79 | -17.7 | -57.9 | -20.1 | -9.66 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.087 | 0.198 | 0.495 | 0.712 | 0.155 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.65 | -6.54 | 16.2 | 4.99 | 1.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.9 | -23.8 | -41 | -14.3 | -8.22 |
| Capital Expenditures | -0.01 | -0.076 | -0.033 | -0.006 | -0.082 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.076 | 0.031 | 0.012 | -3.61 | 2.89 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.066 | -0.045 | -0.021 | -3.62 | 2.81 |
| Financing Cash Flow Items | 0 | -3.2 | -0.002 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 96.4 | -0.112 | 0.001 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.83 | 72.5 | -41.1 | -17.9 | -5.41 |